Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Overview of a promising new study of venetoclax in patients with CLL
Targeted therapy of AML
Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
First results from Bgb-3111 in CLL and Waldenstrom macroglobulinemia